Amara Silva

The assertion that the insurance fleet is primarily a contingent obligation overlooks the crucial competitive advantage it represents. Insurers who succeed exploit this resource as a low-cost investment capital, not just as a simple charge. It is a race for alpha where the most astute managers know how to transform this potential liability into a growth engine, as Berkshire Hathaway has demonstrated by generating massive returns over decades. The real constraint is not the fleet itself but the underwriting discipline; poor management, not the tool's nature, turns it into a burden. Wise Asian players should consider the fleet as a strategic lever for regional expansion.

Thinking that insurance float is perpetual advantage ignores its nature as a contingent liability, a reality that makes its availability very limited.
It is not free capital to deploy arbitrarily; it is money collected for future obligations, a cash flow that we must ration.
In India, SEBI regulations and strict solvency requirements turn this resource into a line item under constant surveillance, not a bonus.
An unexpected series of major claims, such as a major flood, can drain these reserves at an alarming rate, revealing the scarcity of liquidity.

The expansion of Berkshire Hathaway's market capitalization, if it indicates a scale change, does not automatically mean a reduction in its informational advantages or capital allocation flexibility.
If a company of this size maintains a 19.9% annual compounded return, the incentive is clear: it has found ways to continue generating value, often leveraging its strategic liquidity reserves.
For example, Berkshire's ability to deploy massive capital during the 2008 financial crisis demonstrated a flexibility that other giants lacked, challenging the idea of an inevitable constraint.

Claiming that Berkshire's equity investments in 2025 are merely a subcomponent of the 2024 operational cash flows neglects the flexibility of the capital allocation mandate.
Their ability to mobilize funds is not limited to the previous year; regulations allow Berkshire to use its vast cash reserves, as evidenced by their $189 billion in cash as of December 31, 2023, or the proceeds from asset disposals.
An investment approval could very well be financed by a strategic divestment, making the relationship less direct than simple dependency.
The strength of the fortress balance sheet and Berkshire's insurance float give them a discretion that transcends the flows of a single fiscal year.

The residual alpha of 0.1% for Berkshire Hathaway, even after factorial adjustment, is not an irrefutable proof of size restrictions as claimed.
With fresh eyes, should we really conclude that an entity of this scale maintaining a positive, even minimal, alpha is fundamentally constrained?
It resembles more a remarkable performance given its deployed capital than a sign of weakness; just because we have sunk so much attention into the size restriction thesis, it doesn't make it true.
If Berkshire found a massive asymmetric opportunity tomorrow, such as an undervalued company buyout worth several billion, this influence would be conditional and not decisive.